Cibus (CBUS) Current Leases (2018 - 2026)
Cibus (CBUS) posted Current Leases of $2.7 million for Q4 2025, up 2194.96% sequentially from $119000.0 in Q2 2025, and up 2316.81% YoY from $113000.0 in Q4 2024.
Cibus (CBUS) Current Leases (2018 - 2026) Analysis & Trends
Cibus has reported Current Leases for 8 years, with the latest figure at $2.7 million in Q4 2025.
- Quarterly Current Leases rose 2316.81% year-over-year to $2.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.7 million (up 2316.81% YoY) and the FY2025 annual result came in at $2.7 million, up 2316.81% from the prior year.
- Current Leases rose to $2.7 million in Q4 2025 per CBUS's latest filing, from $119000.0 in the prior quarter.
- Over five years, Current Leases peaked at $6.0 million in Q1 2024 and troughed at $105000.0 in Q2 2024.
- A 5-year average of $1.0 million and a median of $268000.0 in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2024 and 2025: Current Leases sank 98.09% in 2024, then jumped 2316.81% in 2025.
- Over 5 years, Current Leases stood at $370000.0 in 2021, then decreased by 0.81% to $367000.0 in 2022, then surged by 1514.99% to $5.9 million in 2023, then tumbled by 98.09% to $113000.0 in 2024, then surged by 2316.81% to $2.7 million in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $2.7 million, $119000.0, and $116000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - | 2.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.86 Mn |
| Dec 31, 2025 | 2.73 Mn |
| Jun 30, 2025 | 119,000.00 |
| Mar 31, 2025 | 116,000.00 |
| Dec 31, 2024 | 113,000.00 |
| Sep 30, 2024 | 110,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Mar 31, 2024 | 5.99 Mn |
| Dec 31, 2023 | 5.93 Mn |
| Sep 30, 2023 | 235,000.00 |
| Jun 30, 2023 | 164,000.00 |
| Dec 31, 2022 | 367,000.00 |
| Sep 30, 2022 | 120,000.00 |
| Jun 30, 2022 | 246,000.00 |
| Mar 31, 2022 | 290,000.00 |
| Dec 31, 2021 | 370,000.00 |
| Sep 30, 2021 | 387,000.00 |
| Jun 30, 2021 | 380,000.00 |
| Mar 31, 2021 | 372,000.00 |
| Dec 31, 2020 | 364,000.00 |